Corrigendum: Shedding light on the shadows: oxidative stress and its pivotal role in prostate cancer progression

A Corrigendum on
Shedding light on the shadows: oxidative stress and its pivotal role in prostate cancer progression

By Biesiadecki M, Mołoń M, Balawender K, Kobylińska Z and Galiniak S (2024). Front. Oncol. 14:1393078. doi: 10.3389/fonc.2024.1393078

In the published article, there was an error in Tables 3–7 as published. The unit of serum Amadori products should be nmol/mg protein instead of μmol/mg protein. A typical unintentional editing mistake was made. The corrected Tables 3–7 appear below.

Table 3

Table 3. Markers of oxidative stress in healthy controls and patients with prostate cancer.

Table 4

Table 4. Markers of oxidative stress in patients divided in groups considering the cancer stage depending on the TNM classification.

Table 5

Table 5. Markers of oxidative stress in patients divided in groups considering Gleason grading system.

Table 6

Table 6. Markers of oxidative stress in patients divided in groups considering the cancer histological grade.

Table 7

Table 7. Markers of oxidative stress in patients divided in groups considering the presence of perineural invasion.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.